MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12931-019-1263-z

Медицинская библиотека · Respiratory research · 2020

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis.

Bennett David, Cameli Paolo, Lanzarone Nicola, Carobene Loredana, Bianchi Nicola, Fui Annalisa, Rizzi Luigi, Bergantini Laura, Cillis Giuseppe, d'Alessandro Miriana, Mazzei Maria Antonietta, Refini Rosa Metella, Sestini Piersante, Bargagli Elena, Rottoli Paola

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease localizations and different radiological lung involvement and to identify clinical features associated with over-expression of chitotriosidase in a large cohort of sarcoidosis patients.

METHODS

Chitotriosidase activity was evaluated in a population of 694 consecutive patients (males 39%, age 55.8 ± 12.8 years). Clinical and respiratory functional characteristics, Clinical Outcome Scale (COS) classification, clinical phenotypes proposed by the GenPhenResA project, and radiological assessment, including CT scan, were collected. Serum sampling and clinical and functional assessments at follow-up were also included.

RESULTS

Significantly higher chitotriosidase activity was observed in sarcoidosis patients than in healthy controls (p < 0.0001). Evidence of lung fibrosis with reticular abnormalities and traction bronchiectasis at High resolution CT, presence of multiple extrapulmonary sarcoid localizations and increased 24-h urinary excretion of calcium were associated with significantly higher chitotriosidase activity (p < 0.005). Patients with remitted or minimal disease had lower values of chitotriosidase than patients with persistent disease. At follow-up, patients who required an increase in steroid dose showed an increase in its activity.

CONCLUSIONS

Chitotriosidase is a reliable biomarker of sarcoidosis. It is increased in patients with sarcoidosis correlating with disease activity, severity and multiorgan dissemination. Steroid therapy tended to reduce chitotriosidase expression, however it responded in cases of disease relapse.

Для цитирования: Bennett David, Cameli Paolo, Lanzarone Nicola, Carobene Loredana, Bianchi Nicola, Fui Annalisa, Rizzi Luigi, Bergantini Laura, Cillis Giuseppe, d'Alessandro Miriana, Mazzei Maria Antonietta, Refini Rosa Metella, Sestini Piersante, Bargagli Elena, Rottoli Paola. Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis.. Respiratory research. 2020. DOI: 10.1186/s12931-019-1263-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.